CClinicalTrials.gg
CompletedNCT06391021TIRADSUpdated May 2, 2024

Comparison Between Combined Scoring of Bethesda Cytology and TIRADS Ultrasound With Histopathology in Thyroid Nodule

An observational study in Thyroid Nodule, sponsored by Tribhuvan University, Nepal. Completed at 1 site in Nepal. Open to participants aged 20 Years to 66 Years. Per ClinicalTrials.gov, last updated 2024-05-02.

Sponsored by Tribhuvan University, Nepal · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
42
Ages
20 Years to 66 Years
Sex
All
01

Study summary

A thyroid nodule is a discrete lesion within the thyroid gland that is radiologically distinct from the surrounding thyroid parenchyma. Most thyroid nodules are benign, with only 10% to 15% harboring cancer. This is a prospective study conducted at the department of Ear, Nose and Throat - Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital , a tertiary heath care centre of Nepal. Individuals visiting ENT-HNS outpatient department with thyroid nodules had undergone Ultrasonography (USG) of neck followed by Fine-Needle Aspiration Cytology (FNAC) from the thyroid nodules. USG was reported by Thyroid Imaging Reporting and Data System(TIRADS) and FNAC by Bethesda system. Thereafter patients were planned either for surgery either total thyroidectomy or hemithyroidectomy. Post operative histopathology was correlated with preoperative FNAC and USG reports.

Read the detailed description

The main objective of this prospective cohort study is to know the correlation between pre- operative Bethesda with post- operative histopathology , pre - operative TIRADS with post operative Histopathology and comparison of combined scoring of Bethesda and TIRADS with histopathology report. It is of utmost importance to deep dive into thyroid nodules workup to detect malignant nodules, as the management aspect of benign and malignant nodules has a vast difference. Thyroid ultrasonography is useful for risk stratification of nodules, and American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) classification provides recommendations for fine-needle aspiration cytology (FNAC) based on objective ultrasonography features of these nodules. To maintain uniformity in reporting system FNA sample are categorized according to the Bethesda system. Total 42 participants who met the inclusion criteria were included in the study. Statistical Analysis was done using Statistical Package for the Social Science (SPSS) version 25. Analysis was done in the form of percentage and proportion and represented as table wherever necessary. Spearman's correlation coefficient was used to evaluate the correlation between Bethesda and TIRADS. Bethesda and histopathology and TIRADS and Bethesda system. The P value was set at \< 0.05 for statistical significance.

02

Conditions studied

  • Thyroid Nodule

Keywords

  • FNAC
  • TIRADS
  • Bethesda
  • Histopathology
03

In context

Thyroid Nodule

200 studies on the registry are indexed under Thyroid Nodule; 57 are open to participants now.

This study's enrollment of 42 is below the median of 200 across 78 observational studies indexed under Thyroid Nodule.

Browse Thyroid Nodule studies →

Lead sponsor

Tribhuvan University, Nepal is the lead sponsor of 16 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 66 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All the participants with thyroid nodules who met the inclusion criteria within the study period were enrolled in the study . Total 42 participants were included in the study.

Inclusion criteria

  • 1.Patients presenting to Ear Nose and Throat, Head and Neck Surgery Department with thyroid nodules undergoing hemithyroidectomy or total thyroidectomy within the study period

Exclusion criteria

Exclusion Criteria:

  • 1.Patients refusing to give consent for the study. 2.Patients with already known case of thyroid malignancies proven by histopathological reports.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
42 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Correlation between Bethesda and TIRADS system

    Correlation between Bethesda and TIRADS system in terms of number of participants belonging to each category

    Time frame: 6 months

  2. Performance measure of Bethesda classification

    Performance measure of Bethesda classification in terms of percentage

    Time frame: 6 months

  3. Performance measure of TIRADS classification

    Performance measure of TIRADS classification in terms of percentage

    Time frame: 6 months

Secondary outcomes

  1. Sex-wise Distribution of thyroid nodule

    Sex-wise Distribution of thyroid nodule in percentage

    Time frame: 6 months

  2. Percentage of participants as per TIRADS classification

    Percentage of participants as per TIRADS classification

    Time frame: 6 months

  3. Number of participants as per histopathological examination

    Number of participants as per histopathological examination

    Time frame: 6 months

  4. Number of participants as per Bethesda classification

    Number of participants as per Bethesda classification

    Time frame: 6 months

  5. Types of surgical procedures performed in terms of percentage

    Types of surgical procedures performed in terms of percentage

    Time frame: 6 months

07

Study locations

1 site
  • Shree Birendra Hospital
    Kathmandu, Bagmati +977, Nepal
08

References and documents

Publications

  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. PubMed 26462967 ↗

Individual participant data

Plan to share: No — There is no plan to share the individual participant data to protect the privacy of the participants.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06391021
Lead sponsor
Tribhuvan University, Nepal
Responsible party
Anupama Marasini (Intern Doctor, Department of Ear, Nose and Throat Head and Neck Surgery, Tribhuvan University, Nepal) — Principal investigator
First posted
Apr 30, 2024
Start date
Jun 20, 2022
Primary completion
Nov 25, 2022
Completion
Feb 15, 2023
Last update
May 2, 2024

Study contacts

Reeba Karki, MS
principal investigator · Shree Birendra Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion